Competition is on the way: Dozens of experimental new weight-loss medications are in development as biotech companies ...
Amylin analogs present a strong alternative or complement to GLP-1 receptor agonists, potentially eliciting higher-quality ...
About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration ...
People taking new weight-loss drugs say they curb cravings for booze, drugs, and nicotine. Did scientists inadvertently ...
The Biden administration is looking to extend Medicare and Medicaid coverage to include obesity drugs like Wegovy and Zepbound. Weight loss drugs are now excluded from mandatory coverage.
In January of 2022, Khoury made it to a place people ... They’ve been successful on powerful new drugs for weight loss, but then they lose access to them. Most employer insurance plans don ...
Ozempic — or any of the GLP-1 class of diet drugs that includes Wegovy and Mounjaro — hasn’t just changed our nation’s ...